Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study].
Hu FL, Cheng H, Zhang XZ, An HJ, Sheng JQ, Lü NH, Xie Y, Chen ZS, Xu JM, Hu NZ, Zheng PY, Zhang L, Zhang LX, Zhang SS, Tao L, Zhang ZY, Cui MH, Yang GB, Wang BM, Jiang K, Yang Q, Gao HJ. Hu FL, et al. Among authors: zhang l, zhang zy, zhang lx, zhang xz, zhang ss. Zhonghua Yi Xue Za Zhi. 2012 Mar 13;92(10):679-84. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22781295 Clinical Trial. Chinese.
[Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study].
Gao W, Cheng H, Hu FL, Lü NH, Xie Y, Sheng JQ, Xu JM, Zhang LX, Zhang L, Chen Y, Zhang ZY, Zhang GX, Cui MH, Yang GB, Gao HJ, Yang L. Gao W, et al. Among authors: zhang l, zhang zy, zhang lx, zhang gx. Zhonghua Yi Xue Za Zhi. 2012 Aug 14;92(30):2108-12. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23158273 Clinical Trial. Chinese.
Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
Xie Y, Zhu Z, Wang J, Zhang L, Zhang Z, Lu H, Zeng Z, Chen S, Liu D, Lv N; the Chinese Study Group on Helicobacter pylori, Chinese Society of Gastroenterology. Xie Y, et al. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00432-18. doi: 10.1128/AAC.00432-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 29914954 Free PMC article. Clinical Trial.
Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
Xie Y, Zhang Z, Hong J, Liu W, Lu H, Du Y, Wang W, Xu J, Wang X, Huo L, Zhang G, Lan C, Li X, Li Y, Wang H, Zhang G, Zhu Y, Shu X, Chen Y, Wang J, Lu N; Chinese Society of Gastroenterology Chinese Study Group on Helicobacter pylori. Xie Y, et al. Helicobacter. 2018 Oct;23(5):e12496. doi: 10.1111/hel.12496. Epub 2018 Jul 22. Helicobacter. 2018. PMID: 30033619 Clinical Trial.
Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study.
Xie Y, Song C, Cheng H, Xu C, Zhang Z, Wang J, Huo L, Du Q, Xu J, Chen Y, Zhang X, Zhang G, Yang G, Zuo X, Guo T, Lu Y, Wang F, Wang X, Zhuang K, Chen S, Liu W, Lu N; Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori and Peptic Ulcer. Xie Y, et al. Emerg Microbes Infect. 2020 Mar 11;9(1):548-557. doi: 10.1080/22221751.2020.1737579. eCollection 2020. Emerg Microbes Infect. 2020. PMID: 32160805 Free PMC article.
Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial.
Shu X, Zhu Z, Fu Y, Zhang Z, Wang J, Li X, He S, Fan H, Liu S, Zhang G, Tang J, Huang C, Du Q, Wang X, Xu B, Du Y, Chen Q, Wang B, Chen Y, Duan X, Xie Y, Huo L, Hou X, Lu N. Shu X, et al. Front Med (Lausanne). 2021 Jul 14;8:690995. doi: 10.3389/fmed.2021.690995. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34336894 Free PMC article.
Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).
Ding SZ, Du YQ, Lu H, Wang WH, Cheng H, Chen SY, Chen MH, Chen WC, Chen Y, Fang JY, Gao HJ, Guo MZ, Han Y, Hou XH, Hu FL, Jiang B, Jiang HX, Lan CH, Li JN, Li Y, Li YQ, Liu J, Li YM, Lyu B, Lu YY, Miao YL, Nie YZ, Qian JM, Sheng JQ, Tang CW, Wang F, Wang HH, Wang JB, Wang JT, Wang JP, Wang XH, Wu KC, Xia XZ, Xie WF, Xie Y, Xu JM, Yang CQ, Yang GB, Yuan Y, Zeng ZR, Zhang BY, Zhang GY, Zhang GX, Zhang JZ, Zhang ZY, Zheng PY, Zhu Y, Zuo XL, Zhou LY, Lyu NH, Yang YS, Li ZS; National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology, and Chinese Alliance for Helicobacter pylori Study. Ding SZ, et al. Among authors: zhang by, zhang zy, zhang gy, zhang jz, zhang gx. Gut. 2022 Feb;71(2):238-253. doi: 10.1136/gutjnl-2021-325630. Epub 2021 Nov 26. Gut. 2022. PMID: 34836916 Free PMC article.
3,448 results